Correlation Between Pfizer and First Quantum

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and First Quantum at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and First Quantum into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc CDR and First Quantum Minerals, you can compare the effects of market volatilities on Pfizer and First Quantum and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of First Quantum. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and First Quantum.

Diversification Opportunities for Pfizer and First Quantum

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pfizer and First is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc CDR and First Quantum Minerals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on First Quantum Minerals and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc CDR are associated (or correlated) with First Quantum. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of First Quantum Minerals has no effect on the direction of Pfizer i.e., Pfizer and First Quantum go up and down completely randomly.

Pair Corralation between Pfizer and First Quantum

Assuming the 90 days trading horizon Pfizer Inc CDR is expected to under-perform the First Quantum. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc CDR is 1.85 times less risky than First Quantum. The stock trades about -0.17 of its potential returns per unit of risk. The First Quantum Minerals is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  1,799  in First Quantum Minerals on September 1, 2024 and sell it today you would earn a total of  114.00  from holding First Quantum Minerals or generate 6.34% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc CDR  vs.  First Quantum Minerals

 Performance 
       Timeline  
Pfizer Inc CDR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Pfizer is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
First Quantum Minerals 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in First Quantum Minerals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, First Quantum displayed solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and First Quantum Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and First Quantum

The main advantage of trading using opposite Pfizer and First Quantum positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, First Quantum can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in First Quantum will offset losses from the drop in First Quantum's long position.
The idea behind Pfizer Inc CDR and First Quantum Minerals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas